Prevalencia del dengue con signos de alarma y su relación con el uso del ibuprofeno en el Hospital General Monte Sinaí 2022 – 2023 : un análisis retrospectivo.

Abstract

Introduction: Dengue is an endemic disease in the region, including Ecuador. Despite its frequency, there is still a high level of self-medication at the onset of symptoms, leading to the use of NSAIDs, which increase the risk of developing dengue with warning signs. Objective: To determine the prevalence of dengue cases with warning signs and the use of ibuprofen at the Hospital General Monte Sinaí during the period 2022 – 2023. Methodology: Descriptive, retrospective, cross-sectional, and correlational study. Results: The prevalence of ibuprofen use in cases of dengue with warning signs was 60.9%, being more frequent in women (69.1%) with an age of presentation between 20 and 40 years (50.6%). The risk of hemorrhage (30.9%) was more frequent in dengue with warning signs, and DENV-2 was associated with lower platelet counts (p < 0.000). Conclusion and recommendation: The use of ibuprofen is frequent in dengue with warning signs, so prevention and promotion of information about the complications that inadequate self-medication can lead to should be prioritized.